Westlake Chemical Co. (NYSE:WLK) Holdings Reduced by Man Group plc

Man Group plc decreased its stake in Westlake Chemical Co. (NYSE:WLK) by 25.1% during the third quarter, according to its most recent disclosure …

Westlake Chemical logoMan Group plc decreased its stake in Westlake Chemical Co. (NYSE:WLK) by 25.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,619 shares of the specialty chemicals company’s stock after selling 15,293 shares during the quarter. Man Group plc’s holdings in Westlake Chemical were worth $3,791,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of WLK. Flagship Harbor Advisors LLC purchased a new stake in shares of Westlake Chemical in the second quarter valued at approximately $130,000. Korea Investment CORP purchased a new position in Westlake Chemical in the second quarter worth approximately $194,000. Standard Life Aberdeen plc purchased a new position in Westlake Chemical in the second quarter worth approximately $226,000. Twin Tree Management LP purchased a new position in Westlake Chemical in the third quarter worth approximately $181,000. Finally, Metropolitan Life Insurance Co. NY grew its position in Westlake Chemical by 47.5% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,721 shares of the specialty chemicals company’s stock worth $293,000 after acquiring an additional 876 shares during the period. Hedge funds and other institutional investors own 29.54% of the company’s stock.

WLK traded up $2.32 during trading on Friday, reaching $77.83. The company’s stock had a trading volume of 960,038 shares, compared to its average volume of 731,133. Westlake Chemical Co. has a 52-week low of $59.78 and a 52-week high of $124.29. The firm has a market capitalization of $10.05 billion, a PE ratio of 14.23, a P/E/G ratio of 0.70 and a beta of 1.47. The company has a current ratio of 2.31, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Westlake Chemical (NYSE:WLK) last posted its quarterly earnings results on Tuesday, November 6th. The specialty chemicals company reported $2.35 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.11. Westlake Chemical had a net margin of 19.36% and a return on equity of 19.75%. The company had revenue of $2.26 billion during the quarter, compared to the consensus estimate of $2.24 billion. During the same period last year, the firm earned $1.61 EPS. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. On average, sell-side analysts predict that Westlake Chemical Co. will post 8.57 EPS for the current year.

Several research analysts recently weighed in on the company. Zacks Investment Research upgraded Westlake Chemical from a “sell” rating to a “hold” rating in a research report on Saturday, December 1st. ValuEngine upgraded Westlake Chemical from a “strong sell” rating to a “sell” rating in a research note on Wednesday, January 9th. Alembic Global Advisors reiterated a “buy” rating on shares of Westlake Chemical in a research report on Monday, November 26th. SunTrust Banks reissued a “positive” rating and set a $81.00 price target on shares of Westlake Chemical in a report on Thursday, November 15th. Finally, BMO Capital Markets set a $94.00 price target on Westlake Chemical and gave the stock a “hold” rating in a report on Thursday, November 8th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the stock. Westlake Chemical has a consensus rating of “Hold” and an average target price of $106.19.

In related news, CEO Albert Chao sold 24,509 shares of Westlake Chemical stock in a transaction that occurred on Thursday, November 15th. The stock was sold at an average price of $71.20, for a total transaction of $1,745,040.80. Following the completion of the transaction, the chief executive officer now directly owns 337,013 shares in the company, valued at approximately $23,995,325.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 72.00% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Westlake Chemical Co. (NYSE:WLK) Holdings Reduced by Man Group plc” was reported by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.fairfieldcurrent.com/news/2019/01/21/man-group-plc-lowers-position-in-westlake-chemical-co-wlk.html.

Westlake Chemical Profile

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Recommended Story: Why are analyst ratings important in trading stocks?

Institutional Ownership by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Westlake Chemical Co. (NYSE:WLK) Stake Lessened by Man Group plc

Man Group plc reduced its position in Westlake Chemical Co. (NYSE:WLK) by 25.1% in the 3rd quarter, according to its most recent filing with the SEC …

Westlake Chemical logoMan Group plc reduced its position in Westlake Chemical Co. (NYSE:WLK) by 25.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 45,619 shares of the specialty chemicals company’s stock after selling 15,293 shares during the period. Man Group plc’s holdings in Westlake Chemical were worth $3,791,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of WLK. Flagship Harbor Advisors LLC purchased a new position in shares of Westlake Chemical in the 2nd quarter worth $130,000. Korea Investment CORP purchased a new position in Westlake Chemical in the second quarter valued at about $194,000. Standard Life Aberdeen plc purchased a new position in Westlake Chemical in the second quarter valued at about $226,000. Twin Tree Management LP purchased a new position in Westlake Chemical in the third quarter valued at about $181,000. Finally, Metropolitan Life Insurance Co. NY raised its position in Westlake Chemical by 47.5% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,721 shares of the specialty chemicals company’s stock valued at $293,000 after purchasing an additional 876 shares during the period. 29.54% of the stock is owned by institutional investors and hedge funds.

NYSE WLK opened at $75.07 on Friday. The firm has a market capitalization of $9.73 billion, a price-to-earnings ratio of 13.72, a P/E/G ratio of 0.69 and a beta of 1.47. Westlake Chemical Co. has a 1 year low of $59.78 and a 1 year high of $124.29. The company has a current ratio of 2.31, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Westlake Chemical (NYSE:WLK) last posted its quarterly earnings results on Tuesday, November 6th. The specialty chemicals company reported $2.35 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.11. Westlake Chemical had a return on equity of 19.75% and a net margin of 19.36%. The company had revenue of $2.26 billion for the quarter, compared to analysts’ expectations of $2.24 billion. During the same quarter in the prior year, the company earned $1.61 earnings per share. The firm’s revenue was up 6.9% on a year-over-year basis. As a group, analysts anticipate that Westlake Chemical Co. will post 8.58 EPS for the current year.

In other Westlake Chemical news, CEO Albert Chao sold 24,509 shares of Westlake Chemical stock in a transaction that occurred on Thursday, November 15th. The shares were sold at an average price of $71.20, for a total transaction of $1,745,040.80. Following the transaction, the chief executive officer now directly owns 337,013 shares in the company, valued at approximately $23,995,325.60. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 72.00% of the company’s stock.

WLK has been the topic of several research reports. Deutsche Bank cut their price objective on Westlake Chemical from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, September 26th. Zacks Investment Research upgraded Westlake Chemical from a “sell” rating to a “hold” rating in a research note on Saturday, December 1st. SunTrust Banks reiterated a “positive” rating and issued a $81.00 price target on shares of Westlake Chemical in a research note on Thursday, November 15th. BMO Capital Markets set a $94.00 price target on Westlake Chemical and gave the stock a “hold” rating in a research note on Thursday, November 8th. Finally, ValuEngine downgraded Westlake Chemical from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 3rd. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $107.12.

ILLEGAL ACTIVITY WARNING: “Westlake Chemical Co. (NYSE:WLK) Stake Lessened by Man Group plc” was originally published by Fairfield Current and is owned by of Fairfield Current. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.fairfieldcurrent.com/news/2019/01/13/man-group-plc-lowers-position-in-westlake-chemical-co-wlk.html.

About Westlake Chemical

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Featured Article: Moving Average (MA)

Institutional Ownership by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Westlake Chemical Co. (NYSE:WLK) Shares Bought by AQR Capital Management LLC

AQR Capital Management LLC raised its position in Westlake Chemical Co. (NYSE:WLK) by 20.0% in the 3rd quarter, according to its most recent …

Westlake Chemical logoAQR Capital Management LLC raised its position in Westlake Chemical Co. (NYSE:WLK) by 20.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,853,189 shares of the specialty chemicals company’s stock after acquiring an additional 308,887 shares during the period. AQR Capital Management LLC owned approximately 1.43% of Westlake Chemical worth $154,018,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in WLK. Flagship Harbor Advisors LLC acquired a new stake in shares of Westlake Chemical during the 2nd quarter worth about $130,000. One Wealth Advisors LLC acquired a new position in Westlake Chemical during the third quarter valued at approximately $160,000. Twin Tree Management LP acquired a new position in Westlake Chemical during the third quarter valued at approximately $181,000. Korea Investment CORP acquired a new position in Westlake Chemical during the second quarter valued at approximately $194,000. Finally, Standard Life Aberdeen plc acquired a new position in Westlake Chemical during the second quarter valued at approximately $226,000. Institutional investors own 29.54% of the company’s stock.

WLK has been the topic of a number of recent research reports. Tudor Pickering cut shares of Westlake Chemical from a “buy” rating to a “hold” rating in a research report on Wednesday, September 19th. Morgan Stanley dropped their price objective on shares of Westlake Chemical from $120.00 to $96.00 and set a “hold” rating on the stock in a research note on Wednesday, September 26th. Deutsche Bank dropped their price objective on shares of Westlake Chemical from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, September 26th. ValuEngine lowered shares of Westlake Chemical from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 3rd. Finally, Barclays initiated coverage on shares of Westlake Chemical in a research note on Monday, October 8th. They set an “overweight” rating and a $100.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the company. Westlake Chemical has a consensus rating of “Hold” and an average target price of $107.12.

In other Westlake Chemical news, CEO Albert Chao sold 24,509 shares of the business’s stock in a transaction dated Thursday, November 15th. The stock was sold at an average price of $71.20, for a total transaction of $1,745,040.80. Following the sale, the chief executive officer now owns 337,013 shares in the company, valued at approximately $23,995,325.60. The transaction was disclosed in a filing with the SEC, which is available through this link. 72.00% of the stock is currently owned by insiders.

WLK stock traded down $0.67 during trading on Friday, hitting $75.07. The company had a trading volume of 646,600 shares, compared to its average volume of 1,056,813. The company has a market capitalization of $9.73 billion, a P/E ratio of 13.72, a PEG ratio of 0.69 and a beta of 1.47. Westlake Chemical Co. has a fifty-two week low of $59.78 and a fifty-two week high of $124.29. The company has a quick ratio of 1.59, a current ratio of 2.31 and a debt-to-equity ratio of 0.44.

Westlake Chemical (NYSE:WLK) last posted its quarterly earnings data on Tuesday, November 6th. The specialty chemicals company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.11. Westlake Chemical had a net margin of 19.36% and a return on equity of 19.75%. The business had revenue of $2.26 billion during the quarter, compared to the consensus estimate of $2.24 billion. During the same quarter in the prior year, the company posted $1.61 earnings per share. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. Equities analysts anticipate that Westlake Chemical Co. will post 8.58 EPS for the current year.

WARNING: This article was first posted by Modern Readers and is owned by of Modern Readers. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.modernreaders.com/news/2019/01/11/aqr-capital-management-llc-purchases-308887-shares-of-westlake-chemical-co-wlk.html.

Westlake Chemical Company Profile

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Featured Article: Stock Symbols, CUSIP and Other Stock Identifiers

Institutional Ownership by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

BlackRock Inc. Increases Stake in Westlake Chemical Co. (WLK)

BlackRock Inc. raised its stake in shares of Westlake Chemical Co. (NYSE:WLK) by 7.6% in the third quarter, according to the company in its most …

Westlake Chemical logoBlackRock Inc. raised its stake in shares of Westlake Chemical Co. (NYSE:WLK) by 7.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,081,307 shares of the specialty chemicals company’s stock after acquiring an additional 147,877 shares during the period. BlackRock Inc. owned approximately 1.61% of Westlake Chemical worth $172,977,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of WLK. Flagship Harbor Advisors LLC purchased a new stake in shares of Westlake Chemical during the 2nd quarter worth approximately $130,000. Korea Investment CORP purchased a new stake in Westlake Chemical in the 2nd quarter valued at $194,000. Standard Life Aberdeen plc purchased a new stake in Westlake Chemical in the 2nd quarter valued at $226,000. Twin Tree Management LP purchased a new stake in Westlake Chemical in the 3rd quarter valued at $181,000. Finally, Raymond James Financial Services Advisors Inc. acquired a new position in Westlake Chemical in the 2nd quarter valued at $234,000. Institutional investors own 29.54% of the company’s stock.

In other Westlake Chemical news, CEO Albert Chao sold 24,509 shares of the stock in a transaction that occurred on Thursday, November 15th. The shares were sold at an average price of $71.20, for a total value of $1,745,040.80. Following the completion of the sale, the chief executive officer now owns 337,013 shares of the company’s stock, valued at $23,995,325.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 72.00% of the stock is owned by company insiders.

Shares of WLK stock traded up $0.38 during trading hours on Thursday, hitting $75.74. 756,882 shares of the company were exchanged, compared to its average volume of 1,114,857. Westlake Chemical Co. has a 1 year low of $59.78 and a 1 year high of $124.29. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.31 and a quick ratio of 1.59. The firm has a market cap of $8.99 billion, a P/E ratio of 13.85, a PEG ratio of 0.68 and a beta of 1.47.

Westlake Chemical (NYSE:WLK) last posted its quarterly earnings results on Tuesday, November 6th. The specialty chemicals company reported $2.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.11. Westlake Chemical had a net margin of 19.36% and a return on equity of 19.75%. The firm had revenue of $2.26 billion for the quarter, compared to analyst estimates of $2.24 billion. During the same quarter last year, the firm posted $1.61 earnings per share. Westlake Chemical’s revenue for the quarter was up 6.9% compared to the same quarter last year. Analysts expect that Westlake Chemical Co. will post 8.55 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 11th. Shareholders of record on Tuesday, November 27th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 1.32%. The ex-dividend date was Monday, November 26th. Westlake Chemical’s dividend payout ratio (DPR) is 18.28%.

WLK has been the topic of several recent research reports. Nomura dropped their price objective on shares of Westlake Chemical from $100.00 to $92.00 and set a “neutral” rating on the stock in a research note on Monday, October 15th. Morgan Stanley dropped their price objective on shares of Westlake Chemical from $120.00 to $96.00 and set a “hold” rating on the stock in a research note on Wednesday, September 26th. ValuEngine cut shares of Westlake Chemical from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 3rd. Deutsche Bank lowered their price target on shares of Westlake Chemical from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, September 26th. Finally, Cowen reaffirmed a “market perform” rating and set a $75.00 price target (down from $100.00) on shares of Westlake Chemical in a research note on Tuesday, December 11th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $107.12.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Fairfield Current and is owned by of Fairfield Current. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.fairfieldcurrent.com/news/2019/01/11/blackrock-inc-has-172-98-million-stake-in-westlake-chemical-co-wlk.html.

Westlake Chemical Profile

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Featured Story: Average Daily Trade Volume Explained

Institutional Ownership by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Westlake Chemical Co. (WLK) Holdings Raised by Meeder Asset Management Inc.

Acadian Asset Management LLC acquired a new stake in shares of Westlake Chemical during the second quarter valued at $357,000. LS Investment …

Westlake Chemical logoMeeder Asset Management Inc. raised its position in Westlake Chemical Co. (NYSE:WLK) by 91.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,693 shares of the specialty chemicals company’s stock after acquiring an additional 10,381 shares during the quarter. Meeder Asset Management Inc.’s holdings in Westlake Chemical were worth $2,335,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Acadian Asset Management LLC acquired a new stake in shares of Westlake Chemical during the second quarter valued at $357,000. LS Investment Advisors LLC purchased a new position in Westlake Chemical during the second quarter worth about $116,000. Cornerstone Wealth Management LLC purchased a new position in Westlake Chemical during the second quarter worth about $1,328,000. James Investment Research Inc. purchased a new position in Westlake Chemical during the second quarter worth about $16,865,000. Finally, Nisa Investment Advisors LLC purchased a new position in Westlake Chemical during the second quarter worth about $1,093,000. 29.97% of the stock is owned by institutional investors.

In other Westlake Chemical news, Chairman James Chao sold 33,305 shares of the firm’s stock in a transaction that occurred on Thursday, May 24th. The stock was sold at an average price of $120.69, for a total transaction of $4,019,580.45. Following the completion of the sale, the chairman now owns 51,492 shares in the company, valued at approximately $6,214,569.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Mark Steven Bender sold 12,066 shares of the firm’s stock in a transaction that occurred on Monday, May 21st. The shares were sold at an average price of $122.83, for a total value of $1,482,066.78. Following the sale, the chief financial officer now owns 27,876 shares of the company’s stock, valued at approximately $3,424,009.08. The disclosure for this sale can be found here. Company insiders own 72.00% of the company’s stock.

Shares of NYSE:WLK traded up $3.05 during mid-day trading on Thursday, hitting $96.93. 969,100 shares of the company traded hands, compared to its average volume of 820,375. The company has a market cap of $12.71 billion, a P/E ratio of 17.72, a PEG ratio of 0.83 and a beta of 1.55. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.51 and a current ratio of 2.27. Westlake Chemical Co. has a 52-week low of $68.93 and a 52-week high of $124.29.

Westlake Chemical (NYSE:WLK) last announced its earnings results on Thursday, August 2nd. The specialty chemicals company reported $2.22 EPS for the quarter, missing the consensus estimate of $2.52 by ($0.30). The company had revenue of $2.24 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Westlake Chemical had a net margin of 18.55% and a return on equity of 19.44%. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.21 earnings per share. analysts predict that Westlake Chemical Co. will post 9.03 earnings per share for the current year.

Several equities analysts recently weighed in on WLK shares. Citigroup reduced their target price on Westlake Chemical from $133.00 to $131.00 and set a “buy” rating on the stock in a research report on Wednesday, July 11th. Zacks Investment Research downgraded Westlake Chemical from a “buy” rating to a “hold” rating in a research report on Wednesday, July 18th. ValuEngine downgraded Westlake Chemical from a “buy” rating to a “hold” rating in a research report on Monday, June 18th. MED restated a “buy” rating and issued a $140.00 price objective on shares of Westlake Chemical in a report on Thursday, August 2nd. Finally, Sanford C. Bernstein started coverage on Westlake Chemical in a report on Wednesday, June 20th. They issued an “outperform” rating and a $150.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $117.71.

Westlake Chemical Company Profile

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products primarily in North America and Europe. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Recommended Story: Outstanding Shares and The Effect on Share Price

Institutional Ownership by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts: